We are live on
!
Find out more
II
IFM Investors Portfolio holdings
AUM
$15.1B
1-Year Est. Return
40.57%
This Fund
S&P 500
This Quarter
Est. Return
+9.83%
1 Year Est. Return
+40.57%
3 Year Est. Return
+130.57%
5 Year Est. Return
+172.93%
10 Year Est. Return
–
AUM
$2.83B
AUM Growth
+$129M
(+4.8%)
Cap. Flow
-$101M
Cap. Flow
% of AUM
-3.55%
Top 10 Holdings %
Top 10 Hldgs %
22.2%
Holding
627
New
19
Increased
62
Reduced
525
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$3.7M |
| 2 |
Blackstone
BX
|
+$3.17M |
| 3 |
Truist Financial
TFC
|
+$3.01M |
| 4 |
RingCentral
RNG
|
+$1.16M |
| 5 |
Insulet
PODD
|
+$972K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$7.53M |
| 2 |
Apple
AAPL
|
+$6.48M |
| 3 |
Microsoft
MSFT
|
+$4.04M |
| 4 |
STI
SunTrust Banks, Inc.
STI
|
+$3.33M |
| 5 |
Amazon
AMZN
|
+$2.83M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.88% |
| 2 | Financials | 15.63% |
| 3 | Healthcare | 13.73% |
| 4 | Communication Services | 10.53% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MPT
526
Medical Properties Trust
MPT
$2.78B
| $801K | 0.03% |
+37,963
| New | +$769K |
|
527
Neurocrine Biosciences
NBIX
$16.6B
| $801K | 0.03% |
+7,453
| New | +$780K |
|
528
Teledyne Technologies
TDY
$31.8B
| $794K | 0.03% |
+2,291
| New | +$770K |
|
529
VICI Properties
VICI
$29.3B
| $792K | 0.03% |
+30,984
| New | +$749K |
|
530
Franklin Resources
BEN
$17.1B
| $787K | 0.03% |
30,305
-2,646
| -8% | -$71.9K |
|
|
ABMD
531
DELISTED
Abiomed Inc
ABMD
| $783K | 0.03% |
4,590
-19
| -0.4% | -$3.52K |
|
|
WBC
532
DELISTED
WABCO HOLDINGS INC.
WBC
| $781K | 0.03% |
5,763
-360
| -6% | -$48.5K |
|
533
West Pharmaceutical
WST
$25B
| $768K | 0.03% |
+5,108
| New | +$744K |
|
534
Owens Corning
OC
$12.2B
| $766K | 0.03% |
11,761
-298
| -2% | -$19.1K |
|
|
DOCU
535
DocuSign
DOCU
$11.4B
| $764K | 0.03% |
10,308
+405
| +4% | +$27.8K |
|
|
ZAYO
536
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $756K | 0.03% |
21,829
-61
| -0.3% | -$2.09K |
|
537
Guidewire Software
GWRE
$13.9B
| $755K | 0.03% |
+6,879
| New | +$769K |
|
|
CTRA
538
DELISTED
Coterra Energy
CTRA
| $748K | 0.03% |
42,978
-3,264
| -7% | -$56.7K |
|
539
DaVita
DVA
$11.5B
| $748K | 0.03% |
9,974
-1,621
| -14% | -$108K |
|
540
Kohl's
KSS
$2.14B
| $748K | 0.03% |
14,676
-1,427
| -9% | -$72.6K |
|
|
HDS
541
DELISTED
HD Supply Holdings, Inc.
HDS
| $737K | 0.03% |
18,320
-521
| -3% | -$20.7K |
|
|
FLIR
542
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $736K | 0.03% |
14,131
-1,339
| -9% | -$70.9K |
|
543
East-West Bancorp
EWBC
$18B
| $735K | 0.03% |
15,084
-484
| -3% | -$21.8K |
|
544
Voya Financial
VOYA
$9.15B
| $728K | 0.03% |
11,934
-1,624
| -12% | -$91.6K |
|
545
Ionis Pharmaceuticals
IONS
$9.2B
| $726K | 0.03% |
12,025
-209
| -2% | -$12.5K |
|
546
XPO
XPO
$23.6B
| $724K | 0.03% |
26,274
-1,784
| -6% | -$49K |
|
|
CDK
547
DELISTED
CDK Global, Inc.
CDK
| $723K | 0.03% |
13,221
-1,482
| -10% | -$76.2K |
|
548
SEI Investments
SEIC
$12.5B
| $719K | 0.03% |
10,978
-1,442
| -12% | -$89.7K |
|
549
Harley-Davidson
HOG
$2.69B
| $718K | 0.03% |
19,318
-1,637
| -8% | -$60.9K |
|
550
Essential Utilities
WTRG
$11.4B
| $718K | 0.03% |
+15,291
| New | +$689K |
|
Similar funds
IA
AT
UM
FCAS
RFC
GF
IFM Investors's Q4 2019 Portfolio in Review
As of Q4 2019, IFM Investors held 627 positions worth $2.83B, up 4.8% from $2.71B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
IFM Investors withdrew a net $101M in Q4 2019, closing 17 positions and reducing 525 holdings. Its most notable exit was Celgene Corp, an estimated $7.53M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
Against the trend, IFM Investors opened a new position in Blackstone worth $3.42M.
- IFM Investors's largest Q4 2019 buy was Blackstone: 61,161 shares worth $3.42M.
- IFM Investors added most to Bristol-Myers Squibb in Q4 2019, an estimated $3.7M increase.
- IFM Investors's biggest Q4 2019 reduction was Apple, cutting an estimated $6.48M.
- IFM Investors fully exited Celgene Corp in Q4 2019, selling an estimated $7.53M.
- IFM Investors's ten largest holdings make up 22% of its $2.83B portfolio in Q4 2019.
- IFM Investors opened 19 new positions and closed 17 in Q4 2019.
- IFM Investors's portfolio value rose 4.8% quarter-over-quarter to $2.83B.
Based on IFM Investors's 13F filing for Q4 2019, filed 13 Jan 2020.